Jerrold B. Grossman - 09 Feb 2026 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Dr. Jerrold B. Grossman, by Adam S. Grossman as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
09 Feb 2026
Net transactions value
$0
Form type
4
Filing time
11 Feb 2026, 21:00:22 UTC
Previous filing
10 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Grossman Jerrold B Director C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY /s/ Dr. Jerrold B. Grossman, by Adam S. Grossman as Attorney-in-fact 11 Feb 2026 0001542519

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Award $0 +10,690 +2.2% $0.000000 488,884 09 Feb 2026 Direct F1, F2
holding ADMA Common Stock 22,857 09 Feb 2026 See footnote F3
holding ADMA Common Stock 31,381 09 Feb 2026 See footnote F4
holding ADMA Common Stock 38,294 09 Feb 2026 See footnote F5
holding ADMA Common Stock 175 09 Feb 2026 See footnote F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Stock Option (Right to Buy) Award $0 +17,730 $0.000000 17,730 09 Feb 2026 Common Stock 17,730 $16.37 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
F2 Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 472,749 shares of common stock owned by the reporting person.
F3 These shares are owned by Brookwood LLC ("Brookwood"). The Reporting Person is the managing member of Brookwood.
F4 These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
F5 These shares are owned by Genesis Foundation Inc. ("Genesis"). The Reporting Person is the President of Genesis.
F6 These shares are owned by the Reporting Person's wife.
F7 These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.